Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alexza Pharmaceuticals Inc (NASDAQ:ALXA)

0.9531
Delayed Data
As of May 27
 -0.0075 / -0.78%
Today’s Change
0.22
Today|||52-Week Range
1.60
+36.16%
Year-to-Date
No recent news for Alexza Pharmaceuticals Inc.

Today’s Trading

Previous close0.96
Today’s open0.95
Day’s range0.94 - 0.98
Volume32,308
Average volume (3 months)157,729
Market cap$20.9M
Dividend yield--
Data as of 05/27/2016

Growth & Valuation

Earnings growth (last year)+47.83%
Earnings growth (this year)-8.33%
Earnings growth (next 5 years)--
Revenue growth (last year)-9.62%
P/E ratioNM
Price/Sales2.76
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PPHMPPeregrine Pharmaceut...-0.04-0.28%
ZSANZosano Pharma Corp0.000.00%
WINTWindtree Therapeutic...-0.01-0.40%
CAPNCapnia Inc-0.08-5.89%
Data as of 05/27/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$5.0M
Annual profit (last year)-$21.3M
Net profit margin-424.00%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, CFO, Director &
CAO
Thomas Braxton King
Vice President-
Operations
Catherine McAuliffe
Corporate headquarters
Mountain View, California

Forecasts

Partner Offers

Search for Jobs